Recombinant CTLA4 & PD1 (Vudalimab Biosimilar) 抗体
The CHO Cells 单克隆 anti-CTLA4 & PD1 (Vudalimab Biosimilar) antibody (ABIN7488355) specifically detects CTLA4 & PD1 (Vudalimab Biosimilar).
The antibody is reactive with 人 samples.
产品编号 ABIN7488355
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CTLA4 & PD1 (Vudalimab Biosimilar) 抗体 (ABIN7488355)
抗原
CTLA4 & PD1 (Vudalimab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
CHO Cells
克隆类型
单克隆
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Vudalimab Biosimilar - Anti-CTLA4,PDCD1 mAb
-
产品特性
- Antibody Type: Bispecific ,IgG1,Kappa,Kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CTLA4 & PD1 (Vudalimab Biosimilar)
-
物质类
- Biosimilar
-
背景
- ANTI-PD-1/ANTI-CTLA-4 XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
抗原
-
You are here:
